title: The use of imaging as biomarkers in drug development: regulatory issues worldwide.
authors.affiliation: Clinic of Nuclear Medicine, Friedrich-Alexander University, Nürnberg-Erlangen, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Katz
authors.forename: H N
authors.initials: HN
authors.lastname: Wagner
authors.forename: M
authors.initials: M
authors.lastname: Fauntleroy
authors.forename: T
authors.initials: T
authors.lastname: Kuwert
authors.forename: R
authors.initials: R
authors.lastname: Frank
mesh_terms: D015415:Biomarkers; D003952:Diagnostic Imaging; D010600:Pharmacology / Q000331:legislation & jurisprudence*; D014055:Tomography, Emission-Computed
chemical_list: D015415:Biomarkers